Please assess the completion status of the following clinical trial:

Trial Title: Innovative Central Line Securement Device in the Pediatric Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a central line ages 0-18 years old who have never worn a wearable central line securement device (vest) will be eligible for the study.~Exclusion Criteria:~* Those children who currently wear a central line securement device (vest)~* Children with central lines who are 19 years or older~* Those females with central lines and Tanner 2 breast or greater breast development as a wearable central line securement device (vest) will not fit properly to secure the central line and may increase the risk of the central line complications.~* If the patient does develop breast during the time of the study then the patient will no longer wear the wrap and will go back to securing their device in the traditional way. The investgators will still collect data on that patient and they will be evaluated in the device arm consistent with the intention to treat principle.

- Gender: ALL
- Minimum Age: 0 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Device (Type: EXPERIMENTAL): Those in the device arm will be given two wearable central line securement devices and the investigators will encourage continuous wear throughout the duration of the study.
- Traditional Securement Dressing (Type: ACTIVE_COMPARATOR): Those is the non-device arm will continue to wear a traditional central line securement dressing as is the standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).